-
1
-
-
0033370811
-
Neuroendocrine cells in tumour growth of the prostate
-
Abrahamsson PA. Neuroendocrine cells in tumour growth of the prostate. Endocr Relat Cancer. 1999;6:503-519
-
(1999)
Endocr Relat Cancer
, vol.6
, pp. 503-519
-
-
Abrahamsson, P.A.1
-
2
-
-
0023201899
-
Peptidehormone-And serotonin-immunoreactive tumour cells in carcinoma of the prostate
-
Abrahamsson PA, Wadstrom LB, Alumets J, et al. Peptidehormone-And serotonin-immunoreactive tumour cells in carcinoma of the prostate. Pathol Res Pract. 1987;182:298-307
-
(1987)
Pathol Res Pract
, vol.182
, pp. 298-307
-
-
Abrahamsson, P.A.1
Wadstrom, L.B.2
Alumets, J.3
-
3
-
-
0027438929
-
Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate
-
Bonkhoff H, Stein U, Remberger K. Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate. Virchows Arch A Pathol Anat Histopathol. 1993;423:291-294
-
(1993)
Virchows Arch A Pathol Anat Histopathol
, vol.423
, pp. 291-294
-
-
Bonkhoff, H.1
Stein, U.2
Remberger, K.3
-
4
-
-
0015103480
-
Argentaffin cells in prostatic carcinoma: Differentiation from lipofuscin and melanin in prostatic epithelium
-
Azzopardi JG, Evans DJ. Argentaffin cells in prostatic carcinoma: Differentiation from lipofuscin and melanin in prostatic epithelium. J Pathol. 1971;104:247-251
-
(1971)
J Pathol
, vol.104
, pp. 247-251
-
-
Azzopardi, J.G.1
Evans, D.J.2
-
5
-
-
0016253641
-
Argentaffin and argyrophil cells in the prostate
-
Kazzaz BA. Argentaffin and argyrophil cells in the prostate. J Pathol. 1974;112:189-193
-
(1974)
J Pathol
, vol.112
, pp. 189-193
-
-
Kazzaz, B.A.1
-
6
-
-
1842788109
-
Neuroendocrine differentiation in hormone refractory prostate cancer following androgen Deprivation therapy
-
Hirano D, Okada Y, Minei S, et al. Neuroendocrine differentiation in hormone refractory prostate cancer following androgen Deprivation therapy. Eur Urol. 2004;45:586-592
-
(2004)
Eur Urol
, vol.45
, pp. 586-592
-
-
Hirano, D.1
Okada, Y.2
Minei, S.3
-
7
-
-
0344457271
-
Neuroendocrine differentiation in prostatic carcinoma
-
Abrahamsson PA. Neuroendocrine differentiation in prostatic carcinoma. Prostate. 1999;39:135-148
-
(1999)
Prostate
, vol.39
, pp. 135-148
-
-
Abrahamsson, P.A.1
-
8
-
-
26844531799
-
Neuroendocrine cells in benign and malignant prostate tissue: Morphogenesis, proliferation, and androgen receptor status
-
Bonkhoff H. Neuroendocrine cells in benign and malignant prostate tissue: Morphogenesis, proliferation, and androgen receptor status. Prostate Suppl. 1998;8:18-22
-
(1998)
Prostate Suppl
, vol.8
, pp. 18-22
-
-
Bonkhoff, H.1
-
9
-
-
0025939537
-
Relation of endocrineparacrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate
-
Bonkhoff H, Wernert N, Dhom G, et al. Relation of endocrineparacrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate. Prostate. 1991;19:91-98
-
(1991)
Prostate
, vol.19
, pp. 91-98
-
-
Bonkhoff, H.1
Wernert, N.2
Dhom, G.3
-
10
-
-
0035876175
-
Neuroendocrine cells in human prostate over-express the anti-Apoptosis protein survivin
-
Xing N, Qian J, Bostwick D, et al. Neuroendocrine cells in human prostate over-express the anti-Apoptosis protein survivin. Prostate. 2001;48:7-15
-
(2001)
Prostate
, vol.48
, pp. 7-15
-
-
Xing, N.1
Qian, J.2
Bostwick, D.3
-
11
-
-
34547699888
-
Chromogranin A expression in patients with hormone naive prostate cancer predicts the development of hormone refractory disease
-
Berruti A, Mosca A, Porpiglia F, et al. Chromogranin A expression in patients with hormone naive prostate cancer predicts the development of hormone refractory disease. J Urol. 2007;178: 838-843
-
(2007)
J Urol
, vol.178
, pp. 838-843
-
-
Berruti, A.1
Mosca, A.2
Porpiglia, F.3
-
12
-
-
0034065893
-
Neuroendocrine expression in metastatic prostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression
-
Mucci NR, Akdas G, Manely S, et al. Neuroendocrine expression in metastatic prostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol. 2000;31:406-414
-
(2000)
Hum Pathol
, vol.31
, pp. 406-414
-
-
Mucci, N.R.1
Akdas, G.2
Manely, S.3
-
13
-
-
79957443342
-
Abiraterone and increased survival in metastatic prostate cancer
-
de Bono JS, Logothetis CJ, Molina A, et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl JMed. 2011; 364:1995-2005
-
(2011)
N Engl JMed
, vol.364
, pp. 1995-2005
-
-
De Bono, J.S.1
Logothetis, C.J.2
Molina, A.3
-
14
-
-
84866770294
-
Increased survival with enzalutamide in prostate cancer after chemotherapy
-
Scher HI, Fizazi K, Saad F, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med. 2012;367: 1187-1197
-
(2012)
N Engl J Med
, vol.367
, pp. 1187-1197
-
-
Scher, H.I.1
Fizazi, K.2
Saad, F.3
-
16
-
-
58149191580
-
Neuroendocrine differentiation in the progression of prostate cancer
-
Komiya A, Suzuki H, Imamoto T, et al. Neuroendocrine differentiation in the progression of prostate cancer. Int J Urol. 2009; 16:37-44
-
(2009)
Int J Urol
, vol.16
, pp. 37-44
-
-
Komiya, A.1
Suzuki, H.2
Imamoto, T.3
-
17
-
-
12344252767
-
Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
-
Vashchenko N, Abrahamsson PA. Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities. Eur Urol. 2005;47:147-155
-
(2005)
Eur Urol
, vol.47
, pp. 147-155
-
-
Vashchenko, N.1
Abrahamsson, P.A.2
-
18
-
-
0026601804
-
Prostate-specific antigen and prostate-specific acid phosphatase in neuroendocrine cells of prostate cancer
-
Cohen RJ, Glezerson G, Haffejee Z. Prostate-specific antigen and prostate-specific acid phosphatase in neuroendocrine cells of prostate cancer. Arch Pathol Lab Med. 1992;116:65-66
-
(1992)
Arch Pathol Lab Med
, vol.116
, pp. 65-66
-
-
Cohen, R.J.1
Glezerson, G.2
Haffejee, Z.3
-
19
-
-
20144388470
-
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease
-
Berruti A, Mosca A, Tucci M, et al. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. Endocr Relat Cancer. 2005;12:109-117
-
(2005)
Endocr Relat Cancer
, vol.12
, pp. 109-117
-
-
Berruti, A.1
Mosca, A.2
Tucci, M.3
-
20
-
-
0036719358
-
Neuroendocrine expression in node positive prostate cancer: Correlation with systemic progression and patient survival
-
Bostwick DG, Qian J, Pacelli A, et al. Neuroendocrine expression in node positive prostate cancer: Correlation with systemic progression and patient survival. J Urol. 2002;168:1204-1211
-
(2002)
J Urol
, vol.168
, pp. 1204-1211
-
-
Bostwick, D.G.1
Qian, J.2
Pacelli, A.3
-
21
-
-
0030722145
-
Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate
-
Theodorescu D, Broder SR, Boyd JC, et al. Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer. 1997;80:2109-2119
-
(1997)
Cancer
, vol.80
, pp. 2109-2119
-
-
Theodorescu, D.1
Broder, S.R.2
Boyd, J.C.3
-
22
-
-
0030015190
-
Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progression after radical prostatectomy
-
Weinstein MH, Partin AW, Veltri RW, et al. Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progression after radical prostatectomy. Hum Pathol. 1996;27:683-687
-
(1996)
Hum Pathol
, vol.27
, pp. 683-687
-
-
Weinstein, M.H.1
Partin, A.W.2
Veltri, R.W.3
-
23
-
-
0025901008
-
Neuro-endocrine cells-A new prognostic parameter in prostate cancer
-
Cohen RJ, Glezerson G, Haffejee Z. Neuro-endocrine cells-A new prognostic parameter in prostate cancer. Br J Urol. 1991;68: 258-262
-
(1991)
Br J Urol
, vol.68
, pp. 258-262
-
-
Cohen, R.J.1
Glezerson, G.2
Haffejee, Z.3
-
24
-
-
33745822086
-
Neuroendocrine differentiation in prostate cancer
-
Shariff AH, Ather MH. Neuroendocrine differentiation in prostate cancer. Urology. 2006;68:2-8
-
(2006)
Urology
, vol.68
, pp. 2-8
-
-
Shariff, A.H.1
Ather, M.H.2
-
25
-
-
0032322346
-
Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies
-
Casella R, Bubendorf L, Sauter G, et al. Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies. J Urol. 1998;160:406-410
-
(1998)
J Urol
, vol.160
, pp. 406-410
-
-
Casella, R.1
Bubendorf, L.2
Sauter, G.3
-
26
-
-
26844482718
-
Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma
-
Abrahamsson PA, Cockett AT, di Sant'Agnese PA. Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma. Prostate Suppl. 1998;8:37-42
-
(1998)
Prostate Suppl
, vol.8
, pp. 37-42
-
-
Abrahamsson, P.A.1
Cockett, A.T.2
Di Sant'Agnese, P.A.3
-
27
-
-
0029047613
-
Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?
-
Allen FJ, Van Velden DJ, Heyns CF. Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?. Br J Urol. 1995;75:751-754
-
(1995)
Br J Urol
, vol.75
, pp. 751-754
-
-
Allen, F.J.1
Van Velden, D.J.2
Heyns, C.F.3
-
28
-
-
0033962683
-
Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment
-
Ahlgren G, Pedersen K, Lundberg S, et al. Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment. Prostate. 2000;42:274-279
-
(2000)
Prostate
, vol.42
, pp. 274-279
-
-
Ahlgren, G.1
Pedersen, K.2
Lundberg, S.3
-
29
-
-
0032982323
-
Prostate cancer and neuroendocrine differentiation
-
Tan MO, Karaoglan U, Celik B, et al. Prostate cancer and neuroendocrine differentiation. Int Urol Nephrol. 1999;31: 75-82
-
(1999)
Int Urol Nephrol
, vol.31
, pp. 75-82
-
-
Tan, M.O.1
Karaoglan, U.2
Celik, B.3
-
30
-
-
0028128330
-
Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression
-
Cohen MK, Arber DA, Coffield KS, et al. Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression. Cancer. 1994;74:1899-1903
-
(1994)
Cancer
, vol.74
, pp. 1899-1903
-
-
Cohen, M.K.1
Arber, D.A.2
Coffield, K.S.3
-
31
-
-
59649093542
-
Immunohistochemical analysis of neuroendocrine differentiation in prostate cancer
-
Ishida E, Nakamura M, Shimada K, et al. Immunohistochemical analysis of neuroendocrine differentiation in prostate cancer. Pathobiology. 2009;76:30-38
-
(2009)
Pathobiology
, vol.76
, pp. 30-38
-
-
Ishida, E.1
Nakamura, M.2
Shimada, K.3
-
32
-
-
84867404902
-
Neuroendocrine differentiation Does not have independent prognostic value in conservatively treated prostate cancer
-
Jeetle SS, Fisher G, Yang ZH, et al. Neuroendocrine differentiation Does not have independent prognostic value in conservatively treated prostate cancer. Virchows Arch. 2012;461:103-107
-
(2012)
Virchows Arch
, vol.461
, pp. 103-107
-
-
Jeetle, S.S.1
Fisher, G.2
Yang, Z.H.3
-
33
-
-
0028214994
-
Neuroendocrine differentiation in metastatic prostatic adenocarcinoma
-
Aprikian AG, Cordon-Cardo C, Fair WR, et al. Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. J Urol. 1994; 151:914-919
-
(1994)
J Urol
, vol.151
, pp. 914-919
-
-
Aprikian, A.G.1
Cordon-Cardo, C.2
Fair, W.R.3
-
34
-
-
0027319765
-
Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma
-
Aprikian AG, Cordon-Cardo C, Fair WR, et al. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer. 1993;71:3952-3965
-
(1993)
Cancer
, vol.71
, pp. 3952-3965
-
-
Aprikian, A.G.1
Cordon-Cardo, C.2
Fair, W.R.3
-
35
-
-
0026567030
-
Paneth cell-like change of the prostate gland A histological, immunohistochemical, and electron microscopic study
-
Weaver MG, Abdul-Karim FW, Srigley J, et al. Paneth cell-like change of the prostate gland A histological, immunohistochemical, and electron microscopic study. Am J Surg Pathol. 1992;16:62-68
-
(1992)
Am J Surg Pathol
, vol.16
, pp. 62-68
-
-
Weaver, M.G.1
Abdul-Karim, F.W.2
Srigley, J.3
-
36
-
-
33747591682
-
Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate
-
Tamas EF, Epstein JI. Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate. Am J Surg Pathol. 2006;30:980-985
-
(2006)
Am J Surg Pathol
, vol.30
, pp. 980-985
-
-
Tamas, E.F.1
Epstein, J.I.2
-
37
-
-
0028354268
-
Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: Report of 30 cases
-
Adlakha H, Bostwick DG. Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: Report of 30 cases. Hum Pathol. 1994;25:135-139
-
(1994)
Hum Pathol
, vol.25
, pp. 135-139
-
-
Adlakha, H.1
Bostwick, D.G.2
-
38
-
-
0742289499
-
Primary and pure neuroendocrine tumor of the prostate
-
Freschi M, Colombo R, Naspro R, et al. Primary and pure neuroendocrine tumor of the prostate. Eur Urol. 2004;45:166-169
-
(2004)
Eur Urol
, vol.45
, pp. 166-169
-
-
Freschi, M.1
Colombo, R.2
Naspro, R.3
-
39
-
-
78549264795
-
A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate
-
Giordano S, Tolonen T, Tolonen T, et al A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate. Int Urol Nephrol. 2010;42:683-687
-
(2010)
Int Urol Nephrol
, vol.42
, pp. 683-687
-
-
Giordano, S.1
Tolonen, T.2
Tolonen, T.3
-
40
-
-
4544227669
-
Prostatic neuroendocrine tumor in multiple endocrine neoplasia type 2B
-
Goulet-Salmon B, Berthe E, Franc S, et al. Prostatic neuroendocrine tumor in multiple endocrine neoplasia type 2B. J Endocrinol Invest. 2004;27:570-573
-
(2004)
J Endocrinol Invest
, vol.27
, pp. 570-573
-
-
Goulet-Salmon, B.1
Berthe, E.2
Franc, S.3
-
41
-
-
0028952423
-
Primary carcinoid of the prostate in conjunction with multiple endocrine neoplasia IIb in a child
-
Whelan T, Gatfield CT, Robertson S, et al. Primary carcinoid of the prostate in conjunction with multiple endocrine neoplasia IIb in a child. J Urol. 1995;153:1080-1082
-
(1995)
J Urol
, vol.153
, pp. 1080-1082
-
-
Whelan, T.1
Gatfield, C.T.2
Robertson, S.3
-
43
-
-
0022403084
-
Carcinoid tumour of the prostate associated with inappropriate ACTH secretion
-
Slater D. Carcinoid tumour of the prostate associated with inappropriate ACTH secretion. Br J Urol. 1985;57:591-592
-
(1985)
Br J Urol
, vol.57
, pp. 591-592
-
-
Slater, D.1
-
44
-
-
0036093676
-
Metastatic carcinoid tumor of the prostate
-
Tash JA, Reuter V, Russo P. Metastatic carcinoid tumor of the prostate. J Urol. 2002;167:2526-2527
-
(2002)
J Urol
, vol.167
, pp. 2526-2527
-
-
Tash, J.A.1
Reuter, V.2
Russo, P.3
-
45
-
-
0018413615
-
Primary carcinoid of prostate
-
Wasserstein PW, Goldman RL. Primary carcinoid of prostate. Urology. 1979;13:318-320
-
(1979)
Urology
, vol.13
, pp. 318-320
-
-
Wasserstein, P.W.1
Goldman, R.L.2
-
46
-
-
33750587865
-
Carcinoid tumors of the urinary tract and prostate
-
Murali R, Kneale K, Lalak N, et al. Carcinoid tumors of the urinary tract and prostate. Arch Pathol Lab Med. 2006;130:1693-1706
-
(2006)
Arch Pathol Lab Med
, vol.130
, pp. 1693-1706
-
-
Murali, R.1
Kneale, K.2
Lalak, N.3
-
47
-
-
0023734347
-
Neuroendocrine differentiation in prostatic carcinomas A retrospective autopsy study
-
Turbat-Herrera EA, Herrera GA, Gore I, et al. Neuroendocrine differentiation in prostatic carcinomas A retrospective autopsy study. Arch Pathol Lab Med. 1988;112:1100-1105
-
(1988)
Arch Pathol Lab Med
, vol.112
, pp. 1100-1105
-
-
Turbat-Herrera, E.A.1
Herrera, G.A.2
Gore, I.3
-
48
-
-
0013508046
-
Mixed carcinoidadenocarcinoma of the prostate with spindle cell carcinoid: The spectrum of neuroendocrine differentiation in prostatic neoplasia
-
Egan AJM, Youngskin TP, Bostwick DG. Mixed carcinoidadenocarcinoma of the prostate with spindle cell carcinoid: The spectrum of neuroendocrine differentiation in prostatic neoplasia. Pathol Case Rev. 1996;1:65-69
-
(1996)
Pathol Case Rev
, vol.1
, pp. 65-69
-
-
Egan, A.J.M.1
Youngskin, T.P.2
Bostwick, D.G.3
-
49
-
-
84873736579
-
Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: A study of 7 cases
-
Lee S, Han JS, Chang A, et al. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: A study of 7 cases. Hum Pathol. 2013;44: 427-431
-
(2013)
Hum Pathol
, vol.44
, pp. 427-431
-
-
Lee, S.1
Han, J.S.2
Chang, A.3
-
50
-
-
0021929670
-
Argyrophilic prostatic carcinoma. Case report with literature review on prostatic carcinoid and "carcinoid-like" prostatic carcinoma
-
Almagro UA. Argyrophilic prostatic carcinoma. case report with literature review on prostatic carcinoid and "carcinoid-like" prostatic carcinoma. Cancer. 1985;55:608-614
-
(1985)
Cancer
, vol.55
, pp. 608-614
-
-
Almagro, U.A.1
-
51
-
-
0021242938
-
Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen
-
Azumi N, Shibuya H, Ishikura M. Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen. Am J Surg Pathol. 1984;8:545-550
-
(1984)
Am J Surg Pathol
, vol.8
, pp. 545-550
-
-
Azumi, N.1
Shibuya, H.2
Ishikura, M.3
-
52
-
-
0021223493
-
Prostatic adenocarcinoma with carcinoidal features producing adrenocorticotropic syndrome. Immunohistochemical study and review of the literature
-
Ghali VS, Garcia RL. Prostatic adenocarcinoma with carcinoidal features producing adrenocorticotropic syndrome. immunohistochemical study and review of the literature. Cancer. 1984;54: 1043-1048
-
(1984)
Cancer
, vol.54
, pp. 1043-1048
-
-
Ghali, V.S.1
Garcia, R.L.2
-
53
-
-
2142827112
-
Primary carcinoid tumor of the prostate with concurrent adenocarcinoma: A case report
-
Ghannoum JE, DeLellis RA, Shin SJ. Primary carcinoid tumor of the prostate with concurrent adenocarcinoma: A case report. Int J Surg Pathol. 2004;12:167-170
-
(2004)
Int J Surg Pathol
, vol.12
, pp. 167-170
-
-
Ghannoum, J.E.1
DeLellis, R.A.2
Shin, S.J.3
-
54
-
-
0022490255
-
Prostatic adenocarcinoma evolving into carcinoid selective effect of hormonal treatment?
-
Stratton M, Evans DJ, Lampert IA. Prostatic adenocarcinoma evolving into carcinoid: Selective effect of hormonal treatment?. J Clin Pathol. 1986;39:750-756
-
(1986)
J Clin Pathol
, vol.39
, pp. 750-756
-
-
Stratton, M.1
Evans, D.J.2
Lampert, I.A.3
-
55
-
-
0023491240
-
Prostatic carcinoma with endocrine features A report of a neoplasm containing multiple immunoreactive hormonal substances
-
Rojas-Corona RR, Chen LZ, Mahadevia PS. Prostatic carcinoma with endocrine features A report of a neoplasm containing multiple immunoreactive hormonal substances. Am J Clin Pathol. 1987;88: 759-762
-
(1987)
Am J Clin Pathol
, vol.88
, pp. 759-762
-
-
Rojas-Corona, R.R.1
Chen, L.Z.2
Mahadevia, P.S.3
-
56
-
-
0018777971
-
Carcinoid tumor of the prostate associated with adenocarcinoma
-
Montasser AY, Ong MG, Mehta VT. Carcinoid tumor of the prostate associated with adenocarcinoma. Cancer. 1979;44:307-310
-
(1979)
Cancer
, vol.44
, pp. 307-310
-
-
Montasser, A.Y.1
Ong, M.G.2
Mehta, V.T.3
-
57
-
-
21644444448
-
Low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate
-
Reyes A, Moran CA. Low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate. Arch Pathol Lab Med. 2004;128:e166-e168
-
(2004)
Arch Pathol Lab Med
, vol.128
-
-
Reyes, A.1
Moran, C.A.2
-
58
-
-
0022618142
-
Prostatic acid phosphatase activity in carcinoid tumors
-
Sobin LH, Hjermstad BM, Sesterhenn IA, et al. Prostatic acid phosphatase activity in carcinoid tumors. Cancer. 1986;58: 136-138
-
(1986)
Cancer
, vol.58
, pp. 136-138
-
-
Sobin, L.H.1
Hjermstad, B.M.2
Sesterhenn, I.A.3
-
59
-
-
37549037864
-
Small cell carcinoma of the prostate A morphologic and immunohistochemical study of 95 cases
-
Wang W, Epstein JI. Small cell carcinoma of the prostate A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol. 2008;32:65-71
-
(2008)
Am J Surg Pathol
, vol.32
, pp. 65-71
-
-
Wang, W.1
Epstein, J.I.2
-
60
-
-
0023191097
-
Small cell carcinoma of the prostate part I A clinicopathologic study of 20 cases
-
Tetu B, Ro JY, Ayala AG, et al. Small cell carcinoma of the prostate. part I A clinicopathologic study of 20 cases. Cancer. 1987; 59:1803-1809
-
(1987)
Cancer
, vol.59
, pp. 1803-1809
-
-
Tetu, B.1
Ro, J.Y.2
Ayala, A.G.3
-
61
-
-
33745890595
-
Small cell carcinoma of the prostate: An immunohistochemical study
-
Yao JL, Madeb R, Bourne P, et al. Small cell carcinoma of the prostate: An immunohistochemical study. Am J Surg Pathol. 2006; 30:705-712
-
(2006)
Am J Surg Pathol
, vol.30
, pp. 705-712
-
-
Yao, J.L.1
Madeb, R.2
Bourne, P.3
-
62
-
-
0023095325
-
Small cell carcinoma of the prostate II immunohistochemical and electron microscopic studies of 18 cases
-
Ro JY, Tetu B, Ayala AG, et al. Small cell carcinoma of the prostate II immunohistochemical and electron microscopic studies of 18 cases. Cancer. 1987;59:977-982
-
(1987)
Cancer
, vol.59
, pp. 977-982
-
-
Ro, J.Y.1
Tetu, B.2
Ayala, A.G.3
-
63
-
-
0034075111
-
Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors
-
Agoff SN, Lamps LW, Philip AT, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol. 2000;13:238-242
-
(2000)
Mod Pathol
, vol.13
, pp. 238-242
-
-
Agoff, S.N.1
Lamps, L.W.2
Philip, A.T.3
-
64
-
-
0033843564
-
Value of thyroid transcription factor-1 immunostaining in Distinguishing small cell lung carcinomas from other small cell carcinomas
-
Ordonez NG. Value of thyroid transcription factor-1 immunostaining in Distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol. 2000;24:1217-1223
-
(2000)
Am J Surg Pathol
, vol.24
, pp. 1217-1223
-
-
Ordonez, N.G.1
-
65
-
-
27344451557
-
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
-
Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644-648
-
(2005)
Science
, vol.310
, pp. 644-648
-
-
Tomlins, S.A.1
Rhodes, D.R.2
Perner, S.3
-
66
-
-
79957912763
-
ERG gene rearrangements are common in prostatic small cell carcinomas
-
Lotan TL, Gupta NS, Wang W, et al. ERG gene rearrangements are common in prostatic small cell carcinomas.Mod Pathol. 2011;24:820-828
-
(2011)
Mod Pathol
, vol.24
, pp. 820-828
-
-
Lotan, T.L.1
Gupta, N.S.2
Wang, W.3
-
67
-
-
68249083702
-
Fluorescence in situ hybridization study shows association of PTEN Deletion with ERG rearrangement during prostate cancer progression
-
Han B, Mehra R, Lonigro RJ, et al. Fluorescence in situ hybridization study shows association of PTEN Deletion with ERG rearrangement during prostate cancer progression. Mod Pathol. 2009;22:1083-1093
-
(2009)
Mod Pathol
, vol.22
, pp. 1083-1093
-
-
Han, B.1
Mehra, R.2
Lonigro, R.J.3
-
68
-
-
78649987427
-
TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate
-
Guo CC, Dancer JY, Wang Y, et al. TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate. Hum Pathol. 2011;42:11-17
-
(2011)
Hum Pathol
, vol.42
, pp. 11-17
-
-
Guo, C.C.1
Dancer, J.Y.2
Wang, Y.3
-
69
-
-
79961031503
-
ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: Evidence supporting monoclonal origin
-
Williamson SR, Zhang S, Yao JL, et al. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: Evidence supporting monoclonal origin. Mod Pathol. 2011;24:1120-1127
-
(2011)
Mod Pathol
, vol.24
, pp. 1120-1127
-
-
Williamson, S.R.1
Zhang, S.2
Yao, J.L.3
-
70
-
-
77953200272
-
ERG rearrangement in small cell prostatic and lung cancer
-
Scheble VJ, Braun M, Wilbertz T, et al. ERG rearrangement in small cell prostatic and lung cancer. Histopathology. 2010;56:937-943
-
(2010)
Histopathology
, vol.56
, pp. 937-943
-
-
Scheble, V.J.1
Braun, M.2
Wilbertz, T.3
-
71
-
-
84884418404
-
Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: The superiority of fluorescence in situ hybridization over ERG immunohistochemistry
-
Schelling LA, Williamson SR, Zhang S, et al. Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: The superiority of fluorescence in situ hybridization over ERG immunohistochemistry. Hum Pathol. 2013;44:2227-2233
-
(2013)
Hum Pathol
, vol.44
, pp. 2227-2233
-
-
Schelling, L.A.1
Williamson, S.R.2
Zhang, S.3
-
72
-
-
84857657168
-
Survival of patients with small cell carcinoma of the prostate during 1973- 2003 A populationbased study
-
Deorah S, Rao MB, Raman R, et al. Survival of patients with small cell carcinoma of the prostate during 1973-2003: A populationbased study. BJU Int. 2012;109:824-830
-
(2012)
BJU Int
, vol.109
, pp. 824-830
-
-
Deorah, S.1
Rao, M.B.2
Raman, R.3
-
73
-
-
0026550416
-
Chemotherapy for small cell carcinoma of prostatic origin
-
Amato RJ, Logothetis CJ, Hallinan R, et al. Chemotherapy for small cell carcinoma of prostatic origin. J Urol. 1992;147:935-937
-
(1992)
J Urol
, vol.147
, pp. 935-937
-
-
Amato, R.J.1
Logothetis, C.J.2
Hallinan, R.3
-
74
-
-
0030811134
-
Small cell anaplastic carcinoma of the prostate: Seven new cases, review of the literature, and discussion of a therapeutic strategy
-
Rubenstein JH, Katin MJ, Mangano MM, et al. Small cell anaplastic carcinoma of the prostate: Seven new cases, review of the literature, and discussion of a therapeutic strategy. Am J Clin Oncol. 1997;20:376-380
-
(1997)
Am J Clin Oncol
, vol.20
, pp. 376-380
-
-
Rubenstein, J.H.1
Katin, M.J.2
Mangano, M.M.3
-
75
-
-
84879853237
-
Platinum-based chemotherapy for variant castrate-resistant prostate cancer
-
Aparicio AM, Harzstark AL, Corn PG, et al. Platinum-based chemotherapy for variant castrate-resistant prostate cancer. Clin Cancer Res. 2013;19:3621-3630
-
(2013)
Clin Cancer Res
, vol.19
, pp. 3621-3630
-
-
Aparicio, A.M.1
Harzstark, A.L.2
Corn, P.G.3
-
76
-
-
0037099524
-
Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate
-
Papandreou CN, Daliani DD, Thall PF, et al. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol. 2002;20:3072-3080
-
(2002)
J Clin Oncol
, vol.20
, pp. 3072-3080
-
-
Papandreou, C.N.1
Daliani, D.D.2
Thall, P.F.3
-
77
-
-
35948929512
-
Neuroendocrine-like prostate cancer cells: Neuroendocrine transdifferentiation of prostate adenocarcinoma cells
-
Yuan TC, Veeramani S, Lin MF. Neuroendocrine-like prostate cancer cells: Neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocr Relat Cancer. 2007;14:531-547
-
(2007)
Endocr Relat Cancer
, vol.14
, pp. 531-547
-
-
Yuan, T.C.1
Veeramani, S.2
Lin, M.F.3
-
78
-
-
84860168795
-
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
-
Beltran H, Rickman DS, Park K, et al. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov. 2011;1:487-495
-
(2011)
Cancer Discov
, vol.1
, pp. 487-495
-
-
Beltran, H.1
Rickman, D.S.2
Park, K.3
-
79
-
-
33745895892
-
Large cell neuroendocrine carcinoma of prostate: A clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer
-
Evans AJ, Humphrey PA, Belani J, et al. Large cell neuroendocrine carcinoma of prostate: A clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer. Am J Surg Pathol. 2006;30:684-693
-
(2006)
Am J Surg Pathol
, vol.30
, pp. 684-693
-
-
Evans, A.J.1
Humphrey, P.A.2
Belani, J.3
-
80
-
-
79953701350
-
Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression profiles
-
Aparicio A, Tzelepi V, Araujo JC, et al. Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression profiles. Prostate. 2011;71:846-856
-
(2011)
Prostate
, vol.71
, pp. 846-856
-
-
Aparicio, A.1
Tzelepi, V.2
Araujo, J.C.3
-
81
-
-
84873048485
-
Concurrent aurka and mycn gene amplifications are harbingers of lethal treatmentrelated neuroendocrine prostate cancer
-
Mosquera JM, Beltran H, Park K, et al. Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatmentrelated neuroendocrine prostate cancer. Neoplasia. 2013;15:1-10.
-
(2013)
Neoplasia
, vol.15
, pp. 1-10
-
-
Mosquera, J.M.1
Beltran, H.2
Park, K.3
|